Vivoryon Therapeutics Company
%20.jpg)
Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.
Funding Status:
IPO
Headquarters:
Halle An Der Saale, Sachsen-Anhalt, Germany
Founded Date:
1-1
Employee Number:
101-250
Last Funding Type:
Private Equity
Total Funding:
$5M
Estimated Revenue:
$1M to $10M
Industry:
Biotechnology, Health Care, Science and Engineering
Investors Number:
1
Technology:
Geroscience
Investor Type:
For Profit